4P Therapeutics

4P develops Products that meet the needs of Patients, Physicians, and Payers.

Transdermal Products

Developing both passive and novel transdermal systems for generics, new chemical entities, biologics, and differentiated products.

In-House Capabilities

Integrated development capabilities, from proof-of-concept to Phase I Clinical testing, and process development and manufacturing

4P Therapeutics

Overview

4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and therapeutics. 4P develops products that meet the needs of patients, physicians and payers. The company has capabilities for developing pharmaceutical products from pre-clinical testing to clinical manufacturing and early stage clinical development (Phase I/II). A key company focus and area of expertise is in the development of transdermal products for currently injected compounds, including proteins, peptides, macromolecules and biologics. Transdermal delivery of commercially available drugs or biologics that are typically delivered via injection has the potential to improve safety, efficacy and therapeutic outcomes associated with these treatments.

Upcoming Events

4P Therapeutics will be attending

  • JP Morgan 35th Annual Healthcare Conference

    San Francisco, CA January 9-13th, 2017

Featured News

News and Articles Highlighting 4P

  • Novel Transdermal Delivery Systems for Treatment of Diabetes

    On Drug Delivery Magazine
  • Transdermal FSH

    4P News Release
  • 4P Therapeutics: Developing New Innovative Transdermal Products

    Drug Development and Delivery Magazine
  • Interview with CEO Steve Damon

    BioTuesdays